| scholarly article | Q13442814 |
| P50 | author | Rodrigo Lima Massara | Q58762944 |
| Marta de Lana | Q58874953 | ||
| P2093 | author name string | O A Martins-Filho | |
| A Teixeira-Carvalho | |||
| R Sathler-Avelar | |||
| J C P Dias | |||
| D M Vitelli-Avelar | |||
| J D Borges | |||
| P S Lage | |||
| S M Elói-Santos | |||
| P2860 | cites work | CD4+CD25+ T regulatory cells inhibit cytotoxic activity of T CD8+ and NK lymphocytes in the direct cell-to-cell interaction | Q33205892 |
| Influence of acute-phase parasite load on pathology, parasitism, and activation of the immune system at the late chronic phase of Chagas' disease | Q34000030 | ||
| The mucin-like glycoprotein super-family of Trypanosoma cruzi: structure and biological roles. | Q34264871 | ||
| The biology of human natural killer-cell subsets | Q34430869 | ||
| Chemokines, inflammation and Trypanosoma cruzi infection. | Q34660986 | ||
| Tumor necrosis factor alpha mediates resistance to Trypanosoma cruzi infection in mice by inducing nitric oxide production in infected gamma interferon-activated macrophages | Q35457307 | ||
| Regulation of Trypanosoma cruzi infection in mice by gamma interferon and interleukin 10: role of NK cells | Q35462159 | ||
| Interleukin-12 mediates resistance to Trypanosoma cruzi in mice and is produced by murine macrophages in response to live trypomastigotes | Q35494931 | ||
| Pivotal role of interleukin-12 and interferon-gamma axis in controlling tissue parasitism and inflammation in the heart and central nervous system during Trypanosoma cruzi infection | Q35750253 | ||
| Going both ways: immune regulation via CD1d-dependent NKT cells | Q35951531 | ||
| Innate and acquired immunity in the pathogenesis of Chagas disease | Q35994773 | ||
| The importance of aberrant T-cell responses in Chagas disease. | Q36101419 | ||
| Evidence that development of severe cardiomyopathy in human Chagas' disease is due to a Th1-specific immune response | Q39730057 | ||
| Monocytes from patients with indeterminate and cardiac forms of Chagas' disease display distinct phenotypic and functional characteristics associated with morbidity | Q40014457 | ||
| Activation of Toll-like receptor-2 by glycosylphosphatidylinositol anchors from a protozoan parasite | Q40797228 | ||
| Glycoconjugates isolated from Trypanosoma cruzi but not from Leishmania species membranes trigger nitric oxide synthesis as well as microbicidal activity in IFN-gamma-primed macrophages | Q41049635 | ||
| Immunological control of Trypanosoma cruzi infection and pathogenesis of Chagas' disease. | Q41617474 | ||
| Human natural killer cells: a unique innate immunoregulatory role for the CD56(bright) subset | Q43600819 | ||
| Human B cell activation by autologous NK cells is regulated by CD40-CD40 ligand interaction: role of memory B cells and CD5+ B cells | Q43803672 | ||
| The Trypanosoma cruzi trans-sialidase is a T cell-independent B cell mitogen and an inducer of non-specific Ig secretion | Q43898130 | ||
| The proinflammatory CD14+CD16+DR++ monocytes are a major source of TNF. | Q43925988 | ||
| Acute Chagas' disease: immunohistochemical characteristics of T cell infiltrate and its relationship with T. cruzi parasitic antigens. | Q44892957 | ||
| Phenotypic features of peripheral blood leucocytes during early stages of human infection with Trypanosoma cruzi | Q47365806 | ||
| Multiple sites of post-activation CD8+ T cell disposal | Q48787238 | ||
| TNF-alpha controls intrahepatic T cell apoptosis and peripheral T cell numbers. | Q51998749 | ||
| Activated T and B lymphocytes in peripheral blood of patients with Chagas' disease. | Q54210625 | ||
| CD4+CD25high regulatory cells in human peripheral blood | Q56905059 | ||
| Proliferative and Cytotoxic capabilities of CD16�CD56?and CD16�CD56+ natural killer cells | Q57609607 | ||
| Chagas' disease: Trypanosoma cruzi vs. the host immune system | Q57842381 | ||
| The human liver contains multiple populations of NK cells, T cells, and CD3+CD56+ natural T cells with distinct cytotoxic activities and Th1, Th2, and Th0 cytokine secretion patterns | Q58143619 | ||
| Cytokine responses in Trypanosoma cruzi-infected children in Paraguay | Q58832376 | ||
| Association of an increase in CD8+ T cells with the presence of Trypanosoma cruzi antigens in chronic, human, chagasic myocarditis | Q58843120 | ||
| Influence of parasite presence on the immunologic profile of peripheral blood mononuclear cells from chagasic patients after specific drug therapy | Q58843278 | ||
| Characterization of inflammatory infiltrates in chronic chagasic myocardial lesions: presence of tumor necrosis factor-alpha+ cells and dominance of granzyme A+, CD8+ lymphocytes | Q58844274 | ||
| Chagasic patients with indeterminate clinical form of the disease have high frequencies of circulating CD3+CD16-CD56+ natural killer T cells and CD4+CD25High regulatory T lymphocytes | Q58845519 | ||
| Control of Chagas disease | Q58846339 | ||
| Chagas' disease | Q58846530 | ||
| Phenotypic characterization of the inflammatory cells in chagasic megaoesophagus | Q58846549 | ||
| Heterogeneity of human blood monocytes: the CD14+ CD16+ subpopulation | Q71648991 | ||
| Glycoinositolphospholipids purified from Trypanosoma cruzi stimulate Ig production in vitro | Q71833938 | ||
| Cord blood CD16+56- cells with low lytic activity are possible precursors of mature natural killer cells | Q73814808 | ||
| Trypanosoma cruzi surface mucin TcMuc-e2 expressed on higher eukaryotic cells induces human T cell anergy, which is reversible | Q77590319 | ||
| P433 | issue | 1 | |
| P921 | main subject | macrophage | Q184204 |
| Chagas disease | Q649558 | ||
| P304 | page(s) | 81-92 | |
| P577 | publication date | 2006-07-01 | |
| P1433 | published in | Clinical and Experimental Immunology | Q15716708 |
| P1476 | title | Are increased frequency of macrophage-like and natural killer (NK) cells, together with high levels of NKT and CD4+CD25high T cells balancing activated CD8+ T cells, the key to control Chagas' disease morbidity? | |
| P478 | volume | 145 |
| Q37499317 | Antigen Presentation by CD1 Lipids, T Cells, and NKT Cells in Microbial Immunity |
| Q36094257 | Association of the Functional MICA-129 Polymorphism With the Severity of Chronic Chagas Heart Disease |
| Q47093622 | Benznidazole affects expression of Th1, Th17 and Treg cytokines during acute experimental Trypanosoma cruzi infection. |
| Q39003348 | Blood Gene Signatures of Chagas Cardiomyopathy With or Without Ventricular Dysfunction |
| Q41485954 | Cellular and genetic mechanisms involved in the generation of protective and pathogenic immune responses in human Chagas disease |
| Q37151780 | Current concepts in immunoregulation and pathology of human Chagas disease |
| Q35114499 | Cytokine profiling in Chagas disease: towards understanding the association with infecting Trypanosoma cruzi discrete typing units (a BENEFIT TRIAL sub-study). |
| Q34251395 | Deficient regulatory T cell activity and low frequency of IL-17-producing T cells correlate with the extent of cardiomyopathy in human Chagas' disease. |
| Q41552272 | Depletion of regulatory T cells decreases cardiac parasitosis and inflammation in experimental Chagas disease |
| Q58843342 | Different parasite inocula determine the modulation of the immune response and outcome of experimental Trypanosoma cruzi infection |
| Q57110653 | Distinct Treatment Outcomes of Antiparasitic Therapy in -Infected Children Is Associated With Early Changes in Cytokines, Chemokines, and T-Cell Phenotypes |
| Q57805344 | Distinct monocyte subset phenotypes in patients with different clinical forms of chronic Chagas disease and seronegative dilated cardiomyopathy |
| Q50987616 | Evaluation of CD4+CD25+ T lymphocyte response time kinetics in patients with chronic Chagas disease after in vitro stimulation with recombinant Trypanosoma cruzi antigens. |
| Q53792154 | Genetic susceptibility to Chagas disease: an overview about the infection and about the association between disease and the immune response genes. |
| Q45341357 | Identification of phenotypic markers of B cells from patients with Chagas disease |
| Q41528104 | Immunoregulatory actions of melatonin and zinc during chronic Trypanosoma cruzi infection |
| Q41745518 | Increase in the expression of CD4 + CD25+ lymphocytic T cells in the indeterminate clinical form of human Chagas disease after stimulation with recombinant antigens of Trypanosoma cruzi |
| Q34009094 | Increased CD4+/CD8+ double-positive T cells in chronic Chagasic patients |
| Q34952422 | Innate immune responses and antioxidant/oxidant imbalance are major determinants of human Chagas disease |
| Q37597066 | Innate immunity and regulatory T-cells in human Chagas disease: what must be understood? |
| Q92405091 | Intermediate Monocytes and Cytokine Production Associated With Severe Forms of Chagas Disease |
| Q35610533 | Killer Cell Immunoglobulin-like Receptors and Their HLA Ligands are Related with the Immunopathology of Chagas Disease. |
| Q36339037 | Lymphocyte subpopulations in myocardial infarction: a comparison between peripheral and intracoronary blood |
| Q27022885 | Modulation of immune response in experimental Chagas disease |
| Q27004131 | Modulation of paraoxonases during infectious diseases and its potential impact on atherosclerosis |
| Q57789637 | Pathology and Pathogenesis of Chagas Heart Disease |
| Q35903600 | Phenotypic Features of Circulating Leukocytes from Non-human Primates Naturally Infected with Trypanosoma cruzi Resemble the Major Immunological Findings Observed in Human Chagas Disease |
| Q35071204 | Polyfunctional T cell responses in children in early stages of chronic Trypanosoma cruzi infection contrast with monofunctional responses of long-term infected adults |
| Q35036373 | Polymorphic sites at the immunoregulatory CTLA-4 gene are associated with chronic chagas disease and its clinical manifestations. |
| Q33927456 | Regulatory T cells phenotype in different clinical forms of Chagas' disease |
| Q34577261 | T lymphocytes from chagasic patients are activated but lack proliferative capacity and down-regulate CD28 and CD3ζ. |
| Q58705710 | The Unsolved Jigsaw Puzzle of the Immune Response in Chagas Disease |
| Q34177376 | Trypanosoma cruzi-induced activation of functionally distinct αβ and γδ CD4- CD8- T cells in individuals with polar forms of Chagas' disease |
| Q92471833 | Vaccines and the regulatory arm of the immune system. An overview from the Trypanosoma cruzi infection model |
Search more.